Research graph
References from Adenovirus infection after cellular therapy: diagnostic and therapeutic challenges. Local targets link to admitted publications; unresolved targets remain external evidence.
Adenovirus infections in immunocompetent and immunocompromised patients
10.1128/cmr.00116-13 · 2014 · External reference
Adenovirus infection in allogeneic hematopoietic cell transplantation
10.1111/tid.14173 · 2023 · External reference
Adenovirus disease after hematopoietic cell transplantation: a Japanese transplant registry analysis
10.1002/ajh.26723 · 2022 · External reference
Adenovirus infections: new insights for the clinical laboratory
10.1128/jcm.00836-22 · 2024 · External reference
Adenovirus persistence, reactivation, and clinical management
10.1002/1873-3468.13576 · 2019 · External reference
Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies
10.1111/petr.14750 · 2024 · External reference
Diagnosis and treatment of adenovirus infection in immunocompromised patients
10.1586/14787210.2013.836964 · 2013 · External reference
A survey on incidence and management of adenovirus infection after allogeneic HSCT
10.1038/s41409-018-0421-0 · 2019 · External reference
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
10.1038/s41409-024-02361-9 · 2024 · External reference
Adenovirus burden in allogeneic hematopoietic stem cell transplantation: monitoring versus symptoms-based testing-a cost-effectiveness analysis
10.1111/tid.70089 · 2025 · External reference
Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation
10.1186/s12985-024-02383-1 · 2024 · External reference
Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: is it alone sufficient to predict adenoviral disease?
10.1111/petr.14696 · 2024 · External reference
Adenovirus infection in pediatric hematopoietic cell transplantation: a challenge still open for survival
10.3390/jcm11164827 · 2022 · External reference
Fields virology
2013 · External reference
Adenovirus
10.1128/microbiolspec.dmih2-0020-2015 · 2016 · External reference
Adenovirus infection and disease in recipients of hematopoietic cell transplantation
10.1097/qco.0000000000000605 · 2019 · External reference
Adenovirus infection and transplantation
10.1097/tp.0000000000003988 · 2022 · External reference
Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral preemptive treatment
10.1016/j.cmi.2015.03.011 · 2015 · External reference
Adenovirus-associated central nervous system disease in children
10.1016/j.jpeds.2018.09.036 · 2019 · External reference
Infections with DNA viruses, adenovirus, polyomaviruses, and parvovirus B19 in hematopoietic stem cell transplant recipients and patients with hematologic malignancies
10.1016/j.idc.2019.02.005 · 2019 · External reference
Human adenovirus species in children with acute respiratory illnesses
10.1016/j.jcv.2020.104716 · 2021 · External reference
Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation
10.1086/319992 · 2001 · External reference
Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: incidence, clinical management, and outcome
10.1111/tid.14215 · 2024 · External reference
Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the AdVance Study
10.1016/j.bbmt.2018.12.753 · 2019 · External reference
Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: multicenter survey of transplant centers in the United States
10.1111/tid.13283 · 2020 · External reference
Incidence and outcomes of adenovirus infections after allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
10.1016/j.jtct.2025.11.029 · 2026 · External reference
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
10.1182/blood-2016-10-748426 · 2017 · External reference
Clinical and economic burden of multiple double-stranded DNA viral infections after allogeneic hematopoietic cell transplantation
10.1016/j.jtct.2022.06.016 · 2022 · External reference
High titers of preexisting adenovirus serotype-specific neutralizing antibodies in the host predict viral reactivation after allogeneic stem cell transplantation in children
10.1093/cid/cir231 · 2011 · External reference
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation
10.1038/leu.2010.4 · 2010 · External reference
Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection posttransplant
10.1016/j.ebiom.2017.12.030 · 2018 · External reference
Comparison of different approaches to quantitative adenovirus detection in stool specimens of hematopoietic stem cell transplant recipients
10.1016/j.jcv.2016.10.021 · 2016 · External reference
Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: the AdVance study
10.1111/ejh.13194 · 2019 · External reference
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience
10.1038/bmt.2013.33 · 2013 · External reference
Incidence of adenoviral DNAemia in Polish adults undergoing allogeneic haematopoietic stem cell transplantation
10.1007/s00005-014-0320-z · 2015 · External reference
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes
10.1080/10428194.2021.1978088 · 2022 · External reference
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome
10.1038/bmt.2010.86 · 2011 · External reference
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
10.1007/s00277-019-03755-2 · 2019 · External reference
Infectious complications in paediatric haematopoetic cell transplantation for acute lymphoblastic leukemia: current status
10.3389/fped.2021.782530 · 2021 · External reference
Adenovirus infection in adult allogeneic hematopoietic stem cell transplant recipients: Systematic review and meta-analysis
10.1016/j.blre.2025.101352 · 2026 · External reference
Incidence and clinical outcomes of multiple viral infections after allogeneic hematopoietic cell transplantation
10.1093/ofid/ofaf597 · 2025 · External reference
Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients-Comparison of current antiviral treatment options
10.1111/tid.13505 · 2021 · External reference
Outcomes of human adenovirus infection and disease in a retrospective cohort of pediatric hematopoietic cell transplant recipients
10.1093/jpids/piy049 · 2019 · External reference
Adenovirus viral kinetics and mortality in ex vivo T cell-depleted hematopoietic cell transplant recipients with adenovirus infection from a single center
10.1093/infdis/jiaa237 · 2020 · External reference
Association between adenovirus infection and mortality outcome among pediatric patients after hematopoietic stem cell transplant
10.1111/tid.13742 · 2021 · External reference
Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study
10.1038/s41409-019-0483-7 · 2019 · External reference
Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant
10.1016/j.jcv.2020.104373 · 2020 · External reference
Pediatric adenovirus infections: 10-year clinical spectrum and predictors of severe disease with emphasis on comorbidities and coinfections
10.1007/s00431-026-06952-0 · 2026 · External reference
Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: a single-center study in Korea
10.1111/tid.12885 · 2018 · External reference
Adenovirus infections in adult recipients of blood and marrow transplants
10.1086/319352 · 2001 · External reference
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - case series and 10 year experience of management in an adult transplant cohort
10.1016/j.jcv.2017.09.013 · 2017 · External reference
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
10.1111/tid.14157 · 2023 · External reference
Infections in haematology patients treated with CAR-T therapies: a systematic review and meta-analysis
10.1016/j.critrevonc.2023.104134 · 2023 · External reference
Current understanding and management of CAR T cell-associated toxicities
10.1038/s41571-024-00903-0 · 2024 · External reference
Impact of adenovirus infection on the long-term cardiovascular and other outcomes following CAR T-cell therapy: a propensity-matched cohort study
10.1182/blood-2025-7683 · 2025 · External reference
Adenovirus in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
10.1111/ctr.13527 · 2019 · External reference
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
10.1016/j.bbmt.2009.06.019 · 2009 · External reference
Comparison of three adenovirus quantitative PCR assays with ATCC reference strains and clinical samples
10.1128/jcm.00735-19 · 2019 · External reference
Viral respiratory infections diagnosed by multiplex polymerase chain reaction in pediatric patients
10.1002/jmv.25379 · 2019 · External reference
Limited diagnostic value of a multiplexed gastrointestinal pathogen panel for the detection of adenovirus infection in an oncology patient population
10.1016/j.jcv.2017.07.002 · 2017 · External reference
Histologic manifestations of gastrointestinal adenovirus infection after stem cell transplant
10.1097/pas.0000000000002197 · 2024 · External reference
Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies
10.1016/j.antiviral.2021.105034 · 2021 · External reference
American Society for Transplantation and Cellular Therapy Series #11: updated cytomegalovirus guidelines in hematopoietic cell transplant and cellular therapy recipients
10.1016/j.jtct.2025.06.025 · 2025 · External reference
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
10.1016/s0002-9394(14)71233-4 · 1995 · External reference
Broad spectrum antiviral nucleosides-our best hope for the future
2021 · External reference
Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir
1996 · External reference
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis
10.1177/0091270002239705 · 2003 · External reference
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study
10.1093/jac/dkab259 · 2021 · External reference
Cidofovir for viral infections in immunocompromised children: guidance on dosing, safety, efficacy, and a review of the literature
10.1177/10600280231176135 · 2024 · External reference
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy
10.1111/j.1399-3046.2007.00851.x · 2008 · External reference
Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients
10.1038/sj.bmt.1704682 · 2004 · External reference
Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection
10.1093/jac/dky192 · 2018 · External reference
Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses
10.1038/s41409-021-01285-y · 2021 · External reference
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant
10.1182/blood-2016-11-749721 · 2017 · External reference
Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial
10.1016/j.bbmt.2016.12.621 · 2017 · External reference
A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation
10.1016/j.bbmt.2018.09.038 · External reference
Pharmacokinetics (PK) and safety of intravenous (IV) brincidofovir (BCV) in healthy adult subjects
10.1093/ofid/ofx163.725 · 2017 · External reference
P-103. Adenoviremia clearance following treatment with intravenous (IV) brincidofovir (BCV) in immunocompromised patients is associated with positive clinical disease response: preliminary outcomes from the ATHENA Phase IIa Study
2025 · External reference
1421. IV brincidofovir (BCV): pharmacokinetics (PK) and safety of multiple ascending doses (MAD) in healthy subjects
10.1093/ofid/ofy210.1252 · 2018 · External reference
Adenovirus infection in hematopoietic and solid organ paediatric transplant recipients: treatment, outcomes, and use of cidofovir
10.3390/microorganisms11071750 · 2023 · External reference
Immunological pathogenesis and treatment progress of adenovirus pneumonia in children
10.1186/s13052-024-01836-1 · 2025 · External reference
A humanized antihuman adenovirus 55 monoclonal antibody with good neutralization ability
10.3389/fimmu.2023.1132822 · 2023 · External reference
Adoptive T-cell therapy for virus-associated diseases
10.1128/cmr.00198-24 · 2025 · External reference
Outcome analysis post virus-specific T cell therapy for the treatment of adenoviremia in immunocompromised pediatric patients
2025 · External reference
Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation
10.1200/jco.2017.73.0655 · 2017 · External reference
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
10.1182/bloodadvances.2017010223 · 2017 · External reference
Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience
10.1111/tid.14296 · 2024 · External reference
Posoleucel, an allogeneic, off-the-shelf multivirus-specific T-cell therapy, for the treatment of refractory viral infections in the post-HCT setting
10.1158/1078-0432.ccr-22-2415 · 2023 · External reference
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
10.1038/s41467-024-47057-2 · 2024 · External reference
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients
10.1182/bloodadvances.2023011562 · 2024 · External reference
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
10.1038/s41467-024-54595-2 · 2024 · External reference
Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
10.1182/blood.v84.5.1689.1689 · 1994 · External reference
Memory T cell donor lymphocyte infusion as a treatment for viral infection after pediatric haploidentical hematopoietic stem cell transplant
10.1016/j.jtct.2025.10.005 · 2026 · External reference
Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory cmv for use in clinical trials: 2024 update From the Transplant Associated Virus Infections Forum
10.1093/cid/ciae321 · 2024 · External reference
Adenovirus persistence, reactivation, and clinical management
10.1002/1873-3468.13576 · ExternalCitation · doi-reference
Adenovirus disease after hematopoietic cell transplantation: a Japanese transplant registry analysis
10.1002/ajh.26723 · ExternalCitation · doi-reference
Viral respiratory infections diagnosed by multiplex polymerase chain reaction in pediatric patients
10.1002/jmv.25379 · ExternalCitation · doi-reference
Incidence of adenoviral DNAemia in Polish adults undergoing allogeneic haematopoietic stem cell transplantation
10.1007/s00005-014-0320-z · ExternalCitation · doi-reference
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
10.1007/s00277-019-03755-2 · ExternalCitation · doi-reference
Pediatric adenovirus infections: 10-year clinical spectrum and predictors of severe disease with emphasis on comorbidities and coinfections
10.1007/s00431-026-06952-0 · ExternalCitation · doi-reference
Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies
10.1016/j.antiviral.2021.105034 · ExternalCitation · doi-reference
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
10.1016/j.bbmt.2009.06.019 · ExternalCitation · doi-reference
Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial
10.1016/j.bbmt.2016.12.621 · ExternalCitation · doi-reference
A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation
10.1016/j.bbmt.2018.09.038 · ExternalCitation · doi-reference
Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the AdVance Study
10.1016/j.bbmt.2018.12.753 · ExternalCitation · doi-reference
Adenovirus infection in adult allogeneic hematopoietic stem cell transplant recipients: Systematic review and meta-analysis
10.1016/j.blre.2025.101352 · ExternalCitation · doi-reference
Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral preemptive treatment
10.1016/j.cmi.2015.03.011 · ExternalCitation · doi-reference
Infections in haematology patients treated with CAR-T therapies: a systematic review and meta-analysis
10.1016/j.critrevonc.2023.104134 · ExternalCitation · doi-reference
Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection posttransplant
10.1016/j.ebiom.2017.12.030 · ExternalCitation · doi-reference
Infections with DNA viruses, adenovirus, polyomaviruses, and parvovirus B19 in hematopoietic stem cell transplant recipients and patients with hematologic malignancies
10.1016/j.idc.2019.02.005 · ExternalCitation · doi-reference
Comparison of different approaches to quantitative adenovirus detection in stool specimens of hematopoietic stem cell transplant recipients
10.1016/j.jcv.2016.10.021 · ExternalCitation · doi-reference
Limited diagnostic value of a multiplexed gastrointestinal pathogen panel for the detection of adenovirus infection in an oncology patient population
10.1016/j.jcv.2017.07.002 · ExternalCitation · doi-reference
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - case series and 10 year experience of management in an adult transplant cohort
10.1016/j.jcv.2017.09.013 · ExternalCitation · doi-reference
Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant
10.1016/j.jcv.2020.104373 · ExternalCitation · doi-reference
Human adenovirus species in children with acute respiratory illnesses
10.1016/j.jcv.2020.104716 · ExternalCitation · doi-reference
Adenovirus-associated central nervous system disease in children
10.1016/j.jpeds.2018.09.036 · ExternalCitation · doi-reference
Clinical and economic burden of multiple double-stranded DNA viral infections after allogeneic hematopoietic cell transplantation
10.1016/j.jtct.2022.06.016 · ExternalCitation · doi-reference
American Society for Transplantation and Cellular Therapy Series #11: updated cytomegalovirus guidelines in hematopoietic cell transplant and cellular therapy recipients
10.1016/j.jtct.2025.06.025 · ExternalCitation · doi-reference
Memory T cell donor lymphocyte infusion as a treatment for viral infection after pediatric haploidentical hematopoietic stem cell transplant
10.1016/j.jtct.2025.10.005 · ExternalCitation · doi-reference
Incidence and outcomes of adenovirus infections after allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
10.1016/j.jtct.2025.11.029 · ExternalCitation · doi-reference
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
10.1016/s0002-9394(14)71233-4 · ExternalCitation · doi-reference
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome
10.1038/bmt.2010.86 · ExternalCitation · doi-reference
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience
10.1038/bmt.2013.33 · ExternalCitation · doi-reference
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation
10.1038/leu.2010.4 · ExternalCitation · doi-reference
A survey on incidence and management of adenovirus infection after allogeneic HSCT
10.1038/s41409-018-0421-0 · ExternalCitation · doi-reference
Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study
10.1038/s41409-019-0483-7 · ExternalCitation · doi-reference
Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses
10.1038/s41409-021-01285-y · ExternalCitation · doi-reference
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
10.1038/s41409-024-02361-9 · ExternalCitation · doi-reference
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
10.1038/s41467-024-47057-2 · ExternalCitation · doi-reference
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
10.1038/s41467-024-54595-2 · ExternalCitation · doi-reference
Current understanding and management of CAR T cell-associated toxicities
10.1038/s41571-024-00903-0 · ExternalCitation · doi-reference
Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients
10.1038/sj.bmt.1704682 · ExternalCitation · doi-reference
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes
10.1080/10428194.2021.1978088 · ExternalCitation · doi-reference
Adenovirus infections in adult recipients of blood and marrow transplants
10.1086/319352 · ExternalCitation · doi-reference
Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation
10.1086/319992 · ExternalCitation · doi-reference
Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory cmv for use in clinical trials: 2024 update From the Transplant Associated Virus Infections Forum
10.1093/cid/ciae321 · ExternalCitation · doi-reference
High titers of preexisting adenovirus serotype-specific neutralizing antibodies in the host predict viral reactivation after allogeneic stem cell transplantation in children
10.1093/cid/cir231 · ExternalCitation · doi-reference
Adenovirus viral kinetics and mortality in ex vivo T cell-depleted hematopoietic cell transplant recipients with adenovirus infection from a single center
10.1093/infdis/jiaa237 · ExternalCitation · doi-reference
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study
10.1093/jac/dkab259 · ExternalCitation · doi-reference
Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection
10.1093/jac/dky192 · ExternalCitation · doi-reference
Outcomes of human adenovirus infection and disease in a retrospective cohort of pediatric hematopoietic cell transplant recipients
10.1093/jpids/piy049 · ExternalCitation · doi-reference
Incidence and clinical outcomes of multiple viral infections after allogeneic hematopoietic cell transplantation
10.1093/ofid/ofaf597 · ExternalCitation · doi-reference
Pharmacokinetics (PK) and safety of intravenous (IV) brincidofovir (BCV) in healthy adult subjects
10.1093/ofid/ofx163.725 · ExternalCitation · doi-reference
1421. IV brincidofovir (BCV): pharmacokinetics (PK) and safety of multiple ascending doses (MAD) in healthy subjects
10.1093/ofid/ofy210.1252 · ExternalCitation · doi-reference
Histologic manifestations of gastrointestinal adenovirus infection after stem cell transplant
10.1097/pas.0000000000002197 · ExternalCitation · doi-reference
Adenovirus infection and disease in recipients of hematopoietic cell transplantation
10.1097/qco.0000000000000605 · ExternalCitation · doi-reference
Adenovirus infection and transplantation
10.1097/tp.0000000000003988 · ExternalCitation · doi-reference
Adenovirus in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
10.1111/ctr.13527 · ExternalCitation · doi-reference
Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: the AdVance study
10.1111/ejh.13194 · ExternalCitation · doi-reference
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy
10.1111/j.1399-3046.2007.00851.x · ExternalCitation · doi-reference
Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: is it alone sufficient to predict adenoviral disease?
10.1111/petr.14696 · ExternalCitation · doi-reference
Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies
10.1111/petr.14750 · ExternalCitation · doi-reference
Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: a single-center study in Korea
10.1111/tid.12885 · ExternalCitation · doi-reference
Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: multicenter survey of transplant centers in the United States
10.1111/tid.13283 · ExternalCitation · doi-reference
Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients-Comparison of current antiviral treatment options
10.1111/tid.13505 · ExternalCitation · doi-reference
Association between adenovirus infection and mortality outcome among pediatric patients after hematopoietic stem cell transplant
10.1111/tid.13742 · ExternalCitation · doi-reference
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
10.1111/tid.14157 · ExternalCitation · doi-reference
Adenovirus infection in allogeneic hematopoietic cell transplantation
10.1111/tid.14173 · ExternalCitation · doi-reference
Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: incidence, clinical management, and outcome
10.1111/tid.14215 · ExternalCitation · doi-reference
Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience
10.1111/tid.14296 · ExternalCitation · doi-reference
Adenovirus burden in allogeneic hematopoietic stem cell transplantation: monitoring versus symptoms-based testing-a cost-effectiveness analysis
10.1111/tid.70089 · ExternalCitation · doi-reference
Adenovirus infections in immunocompetent and immunocompromised patients
10.1128/cmr.00116-13 · ExternalCitation · doi-reference
Adoptive T-cell therapy for virus-associated diseases
10.1128/cmr.00198-24 · ExternalCitation · doi-reference
Comparison of three adenovirus quantitative PCR assays with ATCC reference strains and clinical samples
10.1128/jcm.00735-19 · ExternalCitation · doi-reference
Adenovirus infections: new insights for the clinical laboratory
10.1128/jcm.00836-22 · ExternalCitation · doi-reference
Adenovirus
10.1128/microbiolspec.dmih2-0020-2015 · ExternalCitation · doi-reference
Posoleucel, an allogeneic, off-the-shelf multivirus-specific T-cell therapy, for the treatment of refractory viral infections in the post-HCT setting
10.1158/1078-0432.ccr-22-2415 · ExternalCitation · doi-reference
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis
10.1177/0091270002239705 · ExternalCitation · doi-reference
Cidofovir for viral infections in immunocompromised children: guidance on dosing, safety, efficacy, and a review of the literature
10.1177/10600280231176135 · ExternalCitation · doi-reference
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
10.1182/blood-2016-10-748426 · ExternalCitation · doi-reference
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant
10.1182/blood-2016-11-749721 · ExternalCitation · doi-reference
Impact of adenovirus infection on the long-term cardiovascular and other outcomes following CAR T-cell therapy: a propensity-matched cohort study
10.1182/blood-2025-7683 · ExternalCitation · doi-reference
Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
10.1182/blood.v84.5.1689.1689 · ExternalCitation · doi-reference
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
10.1182/bloodadvances.2017010223 · ExternalCitation · doi-reference
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients
10.1182/bloodadvances.2023011562 · ExternalCitation · doi-reference
Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation
10.1186/s12985-024-02383-1 · ExternalCitation · doi-reference
Immunological pathogenesis and treatment progress of adenovirus pneumonia in children
10.1186/s13052-024-01836-1 · ExternalCitation · doi-reference
Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation
10.1200/jco.2017.73.0655 · ExternalCitation · doi-reference
Diagnosis and treatment of adenovirus infection in immunocompromised patients
10.1586/14787210.2013.836964 · ExternalCitation · doi-reference
A humanized antihuman adenovirus 55 monoclonal antibody with good neutralization ability
10.3389/fimmu.2023.1132822 · ExternalCitation · doi-reference
Infectious complications in paediatric haematopoetic cell transplantation for acute lymphoblastic leukemia: current status
10.3389/fped.2021.782530 · ExternalCitation · doi-reference
Adenovirus infection in pediatric hematopoietic cell transplantation: a challenge still open for survival
10.3390/jcm11164827 · ExternalCitation · doi-reference
Adenovirus infection in hematopoietic and solid organ paediatric transplant recipients: treatment, outcomes, and use of cidofovir
10.3390/microorganisms11071750 · ExternalCitation · doi-reference
